LLY News Explorer
Stay informed with the latest market news and analysis about LLY
2024-11-16
The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
Nov 16, 2024, 9:00 AM
The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded companies.
2024-10-30
Eli Lilly stock sinks after Q3 earnings miss Wall Street expectations
Oct 30, 2024, 7:18 AM
Eli Lilly is set to report Q3 earnings Wednesday, as the pharma giant continues to gain market share in the weight loss drug space.
2024-10-29
Eli Lilly Q3 earnings expected to beat Wall Street expectations
Oct 29, 2024, 5:03 PM
Eli Lilly is set to report Q3 earnings Wednesday, as the pharma giant continues to gain market share in the weight loss drug space.
2024-09-17
Weight-loss drug competition heats up with growing pill market
Sep 17, 2024, 5:32 PM
GLP-1 pills are the next frontier for the weight-loss market.
2024-09-09
Investor's Business Daily executive editor Alissa Coram discusses whether the 'down' stock market is due for a bounce this week on 'Varney & Co.'
2024-09-06
Why Big Pharma is betting on telehealth strategies
Sep 6, 2024, 4:52 PM
The telehealth world is entering a new phase of vertical integration in healthcare.
2024-08-27
Eli Lilly slashes Zepbound prices for self-pay patients
Aug 27, 2024, 10:08 AM
Eli Lilly is trying to reduce shortages of its Zepbound weight loss GLP-1 by launching vials and lowering prices for out-of-pocket payers.
Eli Lilly cuts cost of certain Zepbound doses by at least 50%
Aug 27, 2024, 5:51 AM
Eli Lilly is launching more supply of its weight loss drug Zepbound. The new single-dose vials will be priced lower than "all other incretin GLP-1 medicines for obesity."